The FDA's decision not to convene an AdCom for TNX-102 is promising, but not a guarantee of approval ... to discuss Tonix' NDA for TNX-102. Often, when considering NDAs or Biologics License ...

and commercialization of innovative cell therapies and biologics, today announced that the Pharmaceutical Administration Bureau of the Macao Special Administrative Region (ISAF) has approved the New ...

Fresenius said the U.S. Food and Drug Administration has approved a biologics license application ... on trade policy continues and news on the US economy is looking glum. We sell different ...

The FDA has approved two new denosumab biosimilars that are interchangeable with the reference medications Prolia and Xgeva, ...

around 1935 to gauge public support for the president of the United States during their term. While Gallup has tracked presidential approval for 70 years, other organizations release their ...

Three months into his second term, President Trump hit the highest approval rating he’s ever had as commander-in-chief — while more Americans say the country is on the right track than at any ...

“Expedited Program for Serious Conditions—Accelerated Approval of Drugs and Biologics,” is a game-changer for biopharmaceutical companies hoping to bring life-saving treatments to market. If you’re ...

Here's the latest polls showing Trump's approval rating, with some updated today, March 26, 2025.

The national NBC News poll shows Trump's approval rating at 47% with more registered voters seeing the US as heading in the right direction than at any point since early 2004. Albeit, the majority ...

President Trump's approval rating averages around 46% since taking office for his second term, with a range of 34%-49% throughout his presidency. This rating is higher than his first term average ...

The FDA is reviewing the supplemental NDA for cabozantinib in adults with ... The Company is seeking approval for acute treatment of migraine with or without aura.